COLO B Coloplast A/S Class B

Coloplast launches Saffron™ Fixation System for Prolapse Repair

Coloplast launches Saffron™ Fixation System for Prolapse Repair

Coloplast is introducing the Saffron™ Fixation System designed for ease and reliability during pelvic floor reconstruction for women who suffer from pelvic organ prolapse (POP).

“Our goal was to create an easy-to-use fixation tool that enables physicians to consistently attach sutures to the ligaments of the pelvic floor. We want to invest in products that help surgeons treat women suffering from pelvic floor issues, and Saffron does just that,” says Steve Blum, President of Interventional Urology at Coloplast.





Consistent, reliable deployment; ease of navigation; and more choice

The Saffron™ Fixation System is indicated for attaching sutures to ligaments of the pelvic floor. The system allows for surgeons to use their choice of sutures and needles for POP repair and pairs ease of navigation with consistent, reliable anchor deployment for a secure fixation. It is intuitive and easy to use, and surgeons report high satisfaction1.

“With Saffron, I can easily navigate through the surgical space to access the fixation site, and the unique curve enables perpendicular alignment on the ligament. The tool fits in my hand, is easy to deploy, and the anchor is smooth and secure for my prolapse repairs,” says Dr. Heather van Raalte, medical director of Princeton Urogynecology and the Pelvic Wellness Center in Princeton, NJ. 

Saffron will be commercially available in the US market in the fall of 2022. It joins the existing portfolio of products that Coloplast provides for pelvic floor reconstruction in women.   

For more information, please visit About Coloplast

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound and Skin Care, Interventional Urology, and Voice and Respiratory Care. We operate globally and employ about 14,000 employees.

CONTACTS

Peter Mønster

Sr. Media Relations Manager, Corporate Communications



Aleksandra Dimovska

Director, Investor Relations



1Data on file



 

 

Attachments



EN
06/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Opdateret finanskalender 2025-26

Coloplast A/S - Opdateret finanskalender 2025-26 Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt afholdelsen af den ordinære generalforsamling 2026. De opdaterede datoer er som følger: Årsregnskabsmeddelelse for 2025/26 og Årsrapport 2025/26: ændret fra 5. november 2026 til 3. november 2026Ordinær generalforsamling 2026: ændret fra 3. december 2026 til 1. december 2026 For yderligere information og kalenderinvitationer til kommende beg...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch